Sign up to save your podcasts
Or
Share Gentronix Receives £750K in Third Funding
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gentronix Receives £750K in Third Funding
Matt Tate, CEO, GentronixGentronix Ltd, a UK-based contract research firm, received £750k in third funding.
The Northern Venture Capital Trust Funds (VCTs), which are managed by Mercia, made the investment.
The company intends to use the funds to create 30 new jobs and to expand its capabilities and services.
Led by Matt Tate, CEO, Gentronix provides toxicology testing services for pharmaceuticals, agrochemicals, cosmetics, personal care and consumer products.
Services are delivered by an expert scientific team, with a focus on minimal use of test substances and responsive timeframes. | To read full story, visit https://startuparound.com/read/1579541408.9933586/Gentronix-Receives-£750K-in-Third-Funding?ref=audio_experience
View all episodes
By Startup AroundMatt Tate, CEO, GentronixGentronix Ltd, a UK-based contract research firm, received £750k in third funding.
The Northern Venture Capital Trust Funds (VCTs), which are managed by Mercia, made the investment.
The company intends to use the funds to create 30 new jobs and to expand its capabilities and services.
Led by Matt Tate, CEO, Gentronix provides toxicology testing services for pharmaceuticals, agrochemicals, cosmetics, personal care and consumer products.
Services are delivered by an expert scientific team, with a focus on minimal use of test substances and responsive timeframes. | To read full story, visit https://startuparound.com/read/1579541408.9933586/Gentronix-Receives-£750K-in-Third-Funding?ref=audio_experience